CALGARY, AB, Sept. 29, 2026 /PRNewswire/ -- Providence Therapeutics Holdings, Inc. is pleased to announce formation of its initial Clinical Advisory Board. This advisory group will help steer Providence's therapeutic mRNA cancer vaccine programs, including the Company's personalized vaccine program for pediatric brain cancer patients as well as the...
Recognized for its AI-driven innovation, platform-agnostic product design, and exceptional customer-centric healthcare video solutions SAN ANTONIO, July 23, 2025 /PRNewswire/ -- Frost & Sullivan is...
